ADRA2C and cancer: The data from TIMER 2.0 indicated that there was a positive correlation between ADRA2C expression level and cancer-associated fibroblast in BLCA, BRCA-Basal, CESC, ESCA, HNSC, KIRP, LIHC, STAD, and THYM, as well as a negative correlation in TGCT (Figure 8A).